Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain
PLOS One · 20.03.2026 · 21 (3) · e0345309
DOI: 10.1371/journal.pone.0345309 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.03.2026. Verfasst von Che Suraya Zin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Analgesics, Opioid, Renal Insufficiency, Chronic, Pain. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pain management in chronic kidney disease (CKD) is challenging due to altered drug metabolism, impaired excretion, and higher opioid toxicity risk. Despite this, opioids are commonly prescribed, yet real-world data on dose escalation in CKD remain limited.
Objective
To investigate patterns and timing of opioid dose escalation to ≥50 and ≥90 MME/day among new opioid users across kidney function levels.
Methods
This population-based cohort study used data from the Stockholm Creatinine Measurements (SCREAM) project linking diagnoses, prescriptions, and laboratory records. Adult new opioid users (no prior opioid in 12 months) from 2012–2021 were categorized by baseline eGFR (≥60, 30–59, < 30 mL/min/1.73m²). Opioids were identified using ATC codes, and daily doses (MME/day) were calculated based on strength, quantity, and equianalgesic ratios. Fine–Gray competing-risks regression assessed time to dose escalation (≥50 and ≥90 MME/day), accounting for death as a competing event.
Results
Of 81,987 adult new opioid users, 5,987 (7.3%) escalated to ≥50 MME/day comprising 7.4%, 6.8%, and 8.1% of patients with eGFR ≥ 60, 30–59, and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia.
- Translational Research Center, Instituto Nacional de Pediatria, Mexico City.
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
- Department of Nephrology & Transplantation, Barts Health NHS Trust, London, United Kingdom.
- Pain management Unit, Department of Anaesthesiology, and Intensive Care Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia.
ORCID-Profile: Che Suraya Zin, Shayan Mostafaei, Juan Jesus Carrero
Zitieren
APA
Zin, C. S., Lando, S., González-Ortiz, A., Mahalingasivam, V., Mostafaei, S., Ahmad, W. R., Ahmad Shah, M. M., Wettermark, B., & Carrero, J. J. (2026). Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain. PLOS One, 21(3), e0345309. https://doi.org/10.1371/journal.pone.0345309
Vancouver
Zin CS, Lando S, González-Ortiz A, Mahalingasivam V, Mostafaei S, Ahmad WR, et al. Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain. PLOS One. 2026;21(3):e0345309. doi:10.1371/journal.pone.0345309
BibTeX
@article{Zin2026,
author = {Zin, Che Suraya and Lando, Stefania and González-Ortiz, Ailema and Mahalingasivam, Viyaasan and Mostafaei, Shayan and Ahmad, Wan Rohaidah and Ahmad Shah, Mazlila Meor and Wettermark, Björn and Carrero, Juan Jesus},
title = {Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0345309},
doi = {10.1371/journal.pone.0345309}
}
EUVIMED